October 31, 2017 04:28 PM EDT
Deals

Neos con­sid­er­ing of­fers af­ter re­ject­ing PDL’s $300M bid: Reuters

Brittany Meiling

Neos Ther­a­peu­tics $NEOS may be ask­ing for a bid­ding war af­ter re­ject­ing a takeover of­fer from PDL Bio­Phar­ma that came in last week. A …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times